Aurora Spectral Technologies

About Aurora Spectral Technologies

Aurora Spectral Technologies develops and markets micro-spectroscopy imaging systems. The company has introduced a hyperspectral multiphoton microscopy system, OptiMiS, to the biological and biophysical research markets. The system has utility in multiple domains including basic biological research, prenatal and cancer diagnostics, and drug screening. A combination of spatial and spectral resolution, high sensitivity in regards to photon detection & collection, coupled with fast scanning capabilities and an affordable price-point currently makes the OptiMiS Truline system well positioned to generate significant interest among those in the scientific community concerned with the rapid acquisition of complex multicolor fluorescent images. One such application area is real time imaging studies on live tissue. As an example of one specific application, OptiMiS TruLine facilitates the structural determination of protein aggregates in living cells. This leads to potential uses as a drug screening tool in pharmaceutical research.